Evidence map›Paper›PMID 30807208›Full record

ArticleJCO clinical cancer informatics2019

Classification of Background Parenchymal Uptake on Molecular Breast Imaging Using a Convolutional Neural Network.

Rickey E Carter, Zachi I Attia, Jennifer R Geske, Amy Lynn Conners, Dana H Whaley, Katie N Hunt, Michael K O'Connor, Deborah J Rhodes, Carrie B Hruska

Abstract read
In one paragraph

Article in JCO clinical cancer informatics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Monte Carlo-derivedMedical physics · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rickey E CarterMayo Clinic, Jacksonville, FL.
Zachi I AttiaMayo Clinic, Rochester MN.
Jennifer R GeskeMayo Clinic, Rochester MN.
Amy Lynn ConnersMayo Clinic, Rochester MN.
Dana H WhaleyMayo Clinic, Rochester MN.
Katie N HuntMayo Clinic, Rochester MN.
Michael K O'ConnorMayo Clinic, Rochester MN.
Deborah J RhodesMayo Clinic, Rochester MN.
Carrie B HruskaMayo Clinic, Rochester MN.

Funding

Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Timothy Curry)UL1TR002377 · NCATS · MAYO CLINIC ROCHESTER · PI VESNA D GAROVIC · 2017 to 2026
$78.4M
Background parenchymal uptake (BPU) on molecular breast imaging as a novel breast cancer risk factorR21CA197752 · NCI · MAYO CLINIC ROCHESTER · PI HRUSKA, CARRIE B · 2015 to 2016
$380k
NCATS NIH HHS UL1 TR002377NCI NIH HHS R21 CA197752
6 · The paper itself

Abstract

purposeBackground parenchymal uptake (BPU), which describes the level of radiotracer uptake in normal fibroglandular tissue on molecular breast imaging (MBI), has been identified as a breast cancer risk factor. Our objective was to develop and validate a deep learning model using image convolution to automatically categorize BPU on MBI.

methodsMBI examinations obtained for clinical and research purposes from 2004 to 2015 were reviewed to classify the BPU pattern using a standardized five-category scale. Two expert radiologists provided interpretations that were used as the reference standard for modeling. The modeling consisted of training and validating a convolutional neural network to predict BPU. Model performance was summarized in data reserved to test the performance of the algorithm at the per-image and per-breast levels.

resultsTraining was performed on 24,639 images from 3,133 unique patients. The model performance on the withheld testing data (6,172 images; 786 patients) was evaluated. Using direct matching on the predicted classification resulted in an accuracy of 69.4% (95% CI, 67.4% to 71.3%), and if prediction within one category was considered, accuracy increased to 96.0% (95% CI, 95.2% to 96.7%). When considering the breast-level prediction of BPU, the accuracy remained strong, with 70.3% (95% CI, 68.0% to 72.6%) and 96.2% (95% CI, 95.3% to 97.2%) for the direct match and allowance for one category, respectively.

conclusionBPU provided a robust target for training a convolutional neural network. A validated computer algorithm will allow for objective, reproducible encoding of BPU to foster its integration into risk-stratification algorithms.

Indexed as

Neural Networks, ComputerAlgorithmsBreastBreast NeoplasmsFemaleHumansImage Interpretation, Computer-AssistedMammographyMolecular ImagingParenchymal TissueRadionuclide ImagingRadiopharmaceuticalsRisk AssessmentRisk FactorsRadiopharmaceuticals

Identifiers

PMID30807208
PMCPMC6446086

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.